These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 18426640)
1. [Multiple myeloma: past, present and future--editorial]. Ke XY; Wang YF; Yang YH; Wang LH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):231-9. PubMed ID: 18426640 [TBL] [Abstract][Full Text] [Related]
2. [Multiple myeloma--advances in disease biology and implications for therapy]. Chou T Gan To Kagaku Ryoho; 2001 Sep; 28(9):1206-12. PubMed ID: 11579631 [TBL] [Abstract][Full Text] [Related]
3. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy. Kyle RA Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780 [TBL] [Abstract][Full Text] [Related]
4. Relapsed and refractory multiple myeloma: new therapeutic strategies. Gentili S; Lonial S Hematol Oncol Clin North Am; 2014 Oct; 28(5):861-90. PubMed ID: 25212887 [TBL] [Abstract][Full Text] [Related]
5. Have drug combinations supplanted stem cell transplantation in myeloma? Palumbo A; Cavallo F Blood; 2012 Dec; 120(24):4692-8. PubMed ID: 22730541 [TBL] [Abstract][Full Text] [Related]
6. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma. Lemoli RM; Cavo M; Fortuna A J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709 [TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma. Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar SK Expert Rev Anticancer Ther; 2006 Mar; 6(3):343-60. PubMed ID: 16503852 [TBL] [Abstract][Full Text] [Related]
8. The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma. Joks M; Jurczyszyn A; Machaczka M; Skotnicki AB; Komarnicki M Eur J Haematol; 2015 Feb; 94(2):109-14. PubMed ID: 25039659 [TBL] [Abstract][Full Text] [Related]
14. Carfilzomib and pomalidomide: recent advances in the treatment of multiple myeloma. Highsmith KN; Chen SE; Horowitz S Pharmacotherapy; 2014 Sep; 34(9):927-40. PubMed ID: 25044413 [TBL] [Abstract][Full Text] [Related]
15. The current status of hematopoietic stem cell transplantation for multiple myeloma. Bensinger WI Clin Adv Hematol Oncol; 2004 Jan; 2(1):46-52. PubMed ID: 16163159 [TBL] [Abstract][Full Text] [Related]
16. Thalidomide: present and future in multiple myeloma. Hussein MA Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435 [TBL] [Abstract][Full Text] [Related]
17. Current therapy for multiple myeloma. Rajkumar SV; Gertz MA; Kyle RA; Greipp PR; Mayo Clin Proc; 2002 Aug; 77(8):813-22. PubMed ID: 12173715 [TBL] [Abstract][Full Text] [Related]
18. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma. Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252 [TBL] [Abstract][Full Text] [Related]
19. [The treatment of relapsed or refractory multiple myeloma]. Tsurumi H Nihon Rinsho; 2015 Jan; 73(1):114-8. PubMed ID: 25626315 [TBL] [Abstract][Full Text] [Related]
20. [New trends in the therapy of myeloma]. Jantunen E; Nousiainen T Duodecim; 2000; 116(9):937-9. PubMed ID: 11988994 [No Abstract] [Full Text] [Related] [Next] [New Search]